Service Introduction

Successful Cases

Team Advantage

Provide data management and statistical analysis services for domestic and foreign pharmaceuticals and life science related enterprises, provide targeted solutions according to project characteristics, support the acceleration of research and development progress, and provide excellent services that meet domestic and foreign standards.

● FDA/EMA/PMDA/NMPA filing:

   Dacomitinib first-line treatment of locally advanced or metastatic NSCLC

   harboring EGFR activating mutations

● FDA/EMA filing:

   Enbrel biosimilar candidate SB4/Remicade biosimilar candidate SB2

● NMPA filing:

   Fruquintinib for metastatic colorectal cancer

The educational background of the team includes biostatisticians with overseas background, Ph.D in health economics and Ph.D in medicine, etc. The core team has an average of more than 15 years of experience in the world's top 10 CROs and pharmaceutical companies. More than 300 clinical research experiences, covering multiple disease areas from Phase I to Phase IV, including tumor, cardiovascular, rheumatism and immunity, infectious diseases, etc. The Chinese team has rare international filing experience, including US FDA, European EMA, China NMPA, Japan PMDA, etc.

数据统计
Home
Contact us

Tel:010-53681050

Contact e-mail:contact@medataccess.com

Contact address: Room209B, 2nd floor, Building No. 4,
                           Zhubang 2000 BusinessCenter,
                           No. 100 Balizhuangxili, Chaoyang District,Beijing
Navigation
Scan the code for more
About us
News update
Join us

International standards and quality as a benchmark

Provide customers with all-in-one solutions for the full lifecycle of pharmaceutical products